March 2021- Sirius Medical announced that the U.S. Food and Drug Administration gave it clearance for its Sirius Pintuition System for breast cancer surgery. The device is a non-radioactive approach to localize non-palpable breast tumors.
October 2020- Intersect ENT, Inc. declared the acquisition of Fiagon AG Medical Technologies in a deal worth USD 67.47 million in cash.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?